Skip to content

White Paper

Protecting Products and Patients in Today's Prescription Drug Abuse Epidemic

In this white paper, we discuss the journey behind Lucideon's proprietary iCRT-deter technology. iCRT is a novel series of carriers based on inorganic materials, designed to enhance the delivery of APIs by providing protection of actives and improved stability. iCRT-deter, one of the technologies in this platform, applies all these features, including controlled release to provide protection of high dose or addictive drug formulations, including opioids. 

The escalating prescription abuse problem is discussed, along with Abuse Deterrent Formulation (ADF) drivers and the key factors that shaped the design of iCRT-deter.

Sign in or register to view or download this document

If you have already registered on this website for access to our white papers and other pdf resources, or to watch one of our webinar recordings, you can sign in here.

If you haven’t previously registered, it’s free and the registration process is quick and simple.

Sign inDon't have an account?

Forgot password?

Register nowAlready have an account?

* Denotes a required field

Choose your login details

Your details